Marshall Islands vs Sierra Leone: Tuberculosis treatment success rate by type
Marshall Islands
92
in 2023
Sierra Leone
92
in 2023
Marshall Islands rank
30th
Sierra Leone rank
30th
Tuberculosis treatment success rate by type over time
- Marshall Islands
- Sierra Leone
How they compare
Marshall Islands currently reports 92 against 92 in Sierra Leone, a difference of 0.
The two have swapped places 8 times across 26 shared years of data; in 1995 it was Sierra Leone ahead.
Marshall Islands ranks 30th and Sierra Leone ranks 30th of 194 countries.
Across the 4 decades both report, Marshall Islands averaged higher in 1 and Sierra Leone in 3.
Head to head by decade
| Decade | Marshall Islands | Sierra Leone | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 53.5 | 72 | 18.5 | Sierra Leone |
| 2000s | 83.5 | 82.9 | 0.6 | Marshall Islands |
| 2010s | 79.4 | 87.9 | 8.5 | Sierra Leone |
| 2020s | 87.75 | 91 | 3.25 | Sierra Leone |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate by type, Marshall Islands or Sierra Leone?
- Marshall Islands, at 92 against 92 in Sierra Leone as of 2023.
- What is the difference in tuberculosis treatment success rate by type between Marshall Islands and Sierra Leone?
- 0, with Marshall Islands ahead.
- How many years of comparable data are there for Marshall Islands and Sierra Leone?
- 26 years are reported by both, from 1995 to 2023.
- How do Marshall Islands and Sierra Leone rank globally for tuberculosis treatment success rate by type?
- Marshall Islands ranks 30th and Sierra Leone ranks 30th of 194 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Tuberculosis treatment success rate by type. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The treatment success rate refers to the share of people diagnosed with tuberculosis (TB) who were either cured or completed their treatment according to the country’s treatment guidelines.